Is U.S. drug market impregnable? Korean pharma & bio companies’ accelerated entry to the market

Becoming a global pharmaceutical company has become an topic of conversation among Korean pharmaceutical and biotechnology companies.

A barrier that pharmaceutical and biotechnology companies focusing on R&D consider to ascend a global pharmaceutical company is entry to the U.S. market. The U.S. drug market not only is the world’s largest market, but contains a meaning that a pharmaceutical pr...